March 31, 2003
In Print Photo by Graham Ramsay Focus: Drug Stops Motor Protein, Shines Light on Cell Division Scientists studying how one cell becomes two have a new tool to probe the final, fast stages of division. Aaron Straight, Tim Mitchison (l to r), and colleagues report the discovery of a small compound, blebbistatin, that blocks the final cleavage motion of myosin II, which comes after a cell has duplicated and separated its chromosomes. Using the new drug, they show that timing of the cleavage depends on the cell's protein-reprocessing machinery, the proteasomes.   Publications Online BBS Bulletin Focus HMI World HSTconnector MD-PhD Newsletter MedEd News Mentations On The Brain   Related Links InteliHealth Harvard Health Publications		Headlines Rare Blood Disease Shown to Be a Form of Treatable Cancer Underserved U.S. Minorities Face "Unequal Burden of Cancer" that Must Be Corrected, According to Reports Study Shows How Antioxidants May Be Critical to Preventing Birth Defects in the Babies of Women with Diabetes Multiple Sclerosis Linked to Previous Infection with Epstein-Barr Virus Upcoming Social Medicine Commons Forum: What's in a Condom? HIV and Sexual Politics in Japan Elizabeth Miller, Massachusetts General Hospital Tuesday, April 15 12:30-1:45 p.m. Lab Works A multimedia site featuring Harvard Medical research		Spotlight Match Day: A Rite of Spring On March 20, HMS fourth-years found out where they will spend their residency years. Many were more than pleased. Student Scene Photo by Graham Ramsay Bad Outcomes: A Backdrop for Good Medicine Ellen Rothman tells the story of a missed diagnosis. Knowing the best medicine is not perfect does not make the mistake any easier to accept.

Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home Copyright 2003 by the President and Fellows of Harvard College